A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma von Jagannath, S., Barlogie, B., Berenson, J., Siegel, D., Irwin, D., Richardson, P. G., Niesvizky, R., Alexanian, R., Limentani, S. A., Alsina, M., Adams, J., Kauffman, M., Esseltine, D.‐L., Schenkein, D. P., Anderson, K. C.

Volltext

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa stu... von Martin, M., Fumoleau, P., Dewar, J.A., Albanell, J., Limentani, S.A., Campone, M., Chang, J.C., Patre, M., Strasak, A., de Haas, S.L., Xu, J., Garcia-Saenz, J.A.

Volltext

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy von Diéras, V., Limentani, S., Romieu, G., Tubiana-Hulin, M., Lortholary, A., Kaufman, P., Girre, V., Besenval, M., Valero, V.

Volltext

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer von Gradishar, W.J., Wedam, S.B., Jahanzeb, M., Erban, J., Limentani, S.A., Tsai, K.-T., Olsen, S.R., Swain, S.M.

Volltext

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study von Blackstock, A W, Mornex, F, Partensky, C, Descos, L, Case, L D, Melin, S A, Levine, E A, Mishra, G, Limentani, S A, Kachnic, L A, Tepper, J E

Volltext

Correspondence. The virtuous public health physician von Limentani, S

Volltext

Binding of Human Plasminogen and Urokinase-Type Plasminogen Activator to the Lyme Disease Spirochete, Borrelia burgdorferi von Klempner, Mark S., Noring, Richard, Epstein, Mark P., McCloud, Bruce, Hu, Rong, Limentani, Steven A., Rogers, Rick A.

Volltext

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib von RICHARDSON, Paul G, BRIEMBERG, Hannah, SRKALOVIC, Gordan, ALEXANIAN, Raymond, RAJKUMAR, S. Vincent, LIMENTANI, Steven, ALSINA, Melissa, ORLOWSKI, Robert Z, NAJARIAN, Kevin, ESSELTINE, Dixie, ANDERSON, Kenneth C, AMATO, Anthony A, JAGANNATH, Sundar, WEN, Patrick Y, BARLOGIE, Bart, BERENSON, James, SINGHAL, Seema, SIEGEL, David S, IRWIN, David, SCHUSTER, Michael

Volltext

96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis... von Loibl, S., Huang, C-S., Mano, M.S., Mamounas, T.P., Geyer, C.E., Untch, M., von Minckwitz, G., Thery, J-C., Schwaner, I., Limentani, S., Loman, N., Lübbe, K., Chang, J.C., Hatschek, T., Tesarowski, D., Boulet, T., Wiese, C., Song, C., Wolmark, N.

Volltext

Determination of the electric and magnetic form factors of the proton in the time-like region von Bardin, G., Burgun, G., Calabrese, R., Capon, G., Carlin, R., Dalpiaz, P., Dalpiaz, P.F., Derré, J., Dosselli, U., Duclos, J., Faure, J.L., Gasparini, F., Huet, M., Kochowski, C., Limentani, S., Luppi, E., Marel, G., Mazzucato, E., Meneguzzo, A., Pauli, E., Petrucci, F., Posocco, M., Savrié, M., Strolli, R., Tecchio, L., Voci, C., Zekri, N.

Volltext

A practical guide to the evaluation and treatment of hemophilia von FURIE, B, LIMENTANI, S. A, ROSENFIELD, C. G

Volltext

Acquired free protein S deficiency associated with multiple myeloma: A case report von Deitcher, Steven R., Erban, John K., Limentani, Steven A.

Volltext

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

Abstract P2-10-04: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multi-center trial von Bear, HD, Wan, W, Robidoux, A, Rubin, P, Limentani, S, White, RL, Granfortuna, J, Hopkins, JO, Oldham, D, Rodriguez, A, Sing, AP

Volltext

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa stu... von Martin, M, Fumoleau, P, Dewar, J A, Albanell, J, Limentani, S A, Campone, M, Chang, J C, Patre, M, Strasak, A, de Haas, S L, Xu, J, Garcia-Saenz, J A

Volltext

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial von Mackey, John R, Prof, Martin, Miguel, Prof, Pienkowski, Tadeusz, Prof, Rolski, Janusz, MD, Guastalla, Jean-Paul, MD, Sami, Amer, MD, Glaspy, John, MD, Juhos, Eva, MD, Wardley, Andrew, MD, Fornander, Tommy, MD, Hainsworth, John, MD, Coleman, Robert, MD, Modiano, Manuel R, MD, Vinholes, Jeferson, MD, Pinter, Tamas, MD, Rodríguez-Lescure, Álvaro, MD, Colwell, Bruce, MD, Whitlock, Pierre, MD, Provencher, Louise, MD, Laing, Kara, MD, Walde, David, MD, Price, Chris, MD, Hugh, Judith C, MD, Childs, Barrett H, MD, Bassi, Kimberly, BS, Lindsay, Mary-Ann, PharmD, Wilson, Véronique, MSc, Rupin, Matthieu, MSc, Houé, Vincent, MSc, Vogel, Charles, MD

Volltext

Abstract P4-12-07: Neoadjuvant trastuzumab emtansine and docetaxel, with or without pertuzumab, in patients with HER2-positive early-stage breast cancer: Results from a phase 1b/2a... von Martin, M, Dewar, J, Albanell, J, Limentani, S, Chang, J, Strasak, A, Patre, M, Garcia-Sáenz, JA

Volltext

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma von Richardson, Paul G, Barlogie, Bart, Berenson, James, Singhal, Seema, Jagannath, Sundar, Irwin, David, Rajkumar, S. Vincent, Srkalovic, Gordan, Alsina, Melissa, Alexanian, Raymond, Siegel, David, Orlowski, Robert Z, Kuter, David, Limentani, Steven A, Lee, Stephanie, Hideshima, Teru, Esseltine, Dixie-Lee, Kauffman, Michael, Adams, Julian, Schenkein, David P, Anderson, Kenneth C

Volltext

Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma von Berenson, James R., Jagannath, Sundar, Barlogie, Bart, Siegel, David T., Alexanian, Raymond, Richardson, Paul G., Irwin, David, Alsina, Melissa, Rajkumar, S. Vincent, Srkalovic, Gordon, Singhal, Seema, Limentani, Steven, Niesvizky, Ruben, Esseltine, Dixie L., Trehu, Elizabeth, Schenkein, David P., Anderson, Kenneth

Volltext

The virtuous public health physician von Limentani, Sandro

Volltext